Kestra Private Wealth Services’s Xeris Biopharma Holdings XERS Stock Holding History

Kestra Private Wealth Services’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,832	Closed	-$15.7K	–	1099
2022 Q4	$15.7K	Buy	11,832 +100	+0.9%	+$141	﹤0.01%	886
2022 Q3	$18K	Hold	11,732	–	–	﹤0.01%	887
2022 Q2	$18K	Buy	11,732 +182	+2%	+$384	﹤0.01%	899
2022 Q1	$30K	Hold	11,550	–	–	﹤0.01%	961
2021 Q4	$34K	Sell	11,550 -1,000	-8%	-$2.16K	﹤0.01%	977
2021 Q3	$31K	Hold	12,550	–	–	﹤0.01%	917
2021 Q2	$51K	Hold	12,550	–	–	﹤0.01%	874
2021 Q1	$57K	Hold	12,550	–	–	﹤0.01%	788
2020 Q4	$64K	Sell	12,550 -1,000	-7%	-$5K	﹤0.01%	724
2020 Q3	$80K	Buy	+13,550	New	+$54.2K	0.01%	656

Other funds holding XERS

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Kestra Private Wealth Services's XERS Position: Q1 2023 in Review

Kestra Private Wealth Services sold out of Xeris Biopharma Holdings (XERS) in Q1 2023, closing a stake of 11,832 shares — an estimated $15.7K sold.

Kestra Private Wealth Services first reported a position in XERS in Q3 2020 and held it in 10 quarters. The position peaked at $80K in Q3 2020. 92 funds tracked by Wall St. Rank hold XERS as of Q1 2023.

Kestra Private Wealth Services reported no remaining Xeris Biopharma Holdings position as of Q1 2023 after selling out during the quarter.
Kestra Private Wealth Services sold 11,832 Xeris Biopharma Holdings shares in Q1 2023, an estimated $15.7K.
Kestra Private Wealth Services first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 10 quarters.
Kestra Private Wealth Services's Xeris Biopharma Holdings position peaked at $80K in Q3 2020.
92 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2023.

Based on Kestra Private Wealth Services's 13F filing for Q1 2023, filed 12 May 2023.